» Articles » PMID: 39295864

Genetic Association and Causal Effects Between Inflammatory Bowel Disease and Conjunctivitis

Overview
Journal Front Immunol
Date 2024 Sep 19
PMID 39295864
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Inflammatory bowel disease (IBD) is often clinically associated with conjunctivitis, which may result from genetic associations and causal effects.

Methods: Genetic correlations were investigated through the genome-wide association study (GWAS) data on IBD and conjunctivitis using the linkage disequilibrium score regression (LDSC) and heritability estimated in summary statistics (HESS). The causal effect analysis was performed using four methods of Mendelian randomization (MR) and the genetic risk loci common to both diseases were identified by the statistical method of conditional/conjoint false discovery rate (cond/conjFDR), followed by genetic overlap analysis. Finally, a multi-trait GWAS analysis (MTAG) was performed to validate the identified shared loci.

Results: IBD (including CD and UC) and conjunctivitis showed a significant overall correlation at the genomic level; however, the local correlation of IBD and CD with conjunctivitis was significant and limited to chromosome 11. MR analysis suggested a significant positive and non-significant negative correlation between IBD (including CD and UC) and conjunctivitis. The conjFDR analysis confirmed the genetic overlap between the two diseases. Additionally, MTAG was employed to identify and validate multiple genetic risk loci.

Conclusion: The present study provides evidence of genetic structure and causal effects for the co-morbidity between IBD (both CD and UC) and conjunctivitis, expanding the epidemiologic understanding of the two diseases.

Citing Articles

Shared genetic architecture between COVID-19 and irritable bowel syndrome: a large-scale genome-wide cross-trait analysis.

Liu X, Li D, Gao W, Liu H, Chen P, Zhao Y Front Immunol. 2024; 15:1442693.

PMID: 39620219 PMC: 11604633. DOI: 10.3389/fimmu.2024.1442693.

References
1.
Smeland O, Frei O, Shadrin A, OConnell K, Fan C, Bahrami S . Discovery of shared genomic loci using the conditional false discovery rate approach. Hum Genet. 2019; 139(1):85-94. DOI: 10.1007/s00439-019-02060-2. View

2.
Luo Q, Zhou P, Chang S, Huang Z, Zhu Y . The gut-lung axis: Mendelian randomization identifies a causal association between inflammatory bowel disease and interstitial lung disease. Heart Lung. 2023; 61:120-126. DOI: 10.1016/j.hrtlng.2023.05.016. View

3.
Salmon J, Wright J, Murray A . Ocular inflammation in Crohn's disease. Ophthalmology. 1991; 98(4):480-4. DOI: 10.1016/s0161-6420(91)32268-1. View

4.
Menesy A, Hammad M, Aref S, Abozeid F . Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity. BMC Gastroenterol. 2024; 24(1):135. PMC: 11020998. DOI: 10.1186/s12876-024-03218-7. View

5.
Rowan S, Jiang S, Korem T, Szymanski J, Chang M, Szelog J . Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci U S A. 2017; 114(22):E4472-E4481. PMC: 5465926. DOI: 10.1073/pnas.1702302114. View